|
|
(State or Other Jurisdiction of Incorporation)
|
(I.R.S. Employer Identification No.)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
||
Exhibit
Number |
|
Description
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
BERRY GLOBAL GROUP, INC.
(Registrant)
|
|||
|
By:
|
/s/ Jason K. Greene |
|
Dated: November 19, 2024 |
Name: |
Jason K. Greene |
|
Title: |
Executive Vice President, Chief Legal Officer and Secretary |
||
Kevin Kwilinski, Berry’s CEO, stated, “With the successful completion of the HHNF transaction, Berry is now a leading pure-play supplier of
sustainable global packaging solutions. This intentional emphasis on fast-moving consumer goods will result in even more predictable earnings growth and cash generation, providing stability and resilience to our business as we continue
to optimize our portfolio.
As a result of our team’s outstanding performance we ended fiscal 2024 on a strong note, achieving 2% organic volume growth, excluding HHNF,
in our underlying businesses and over 6% earnings per share growth in the second half. We also reached our leverage goal of 3.5x, the lowest in the company’s history. Our lean transformation and customer excellence initiatives
contributed to positive volumes again this quarter, as we continue to navigate a challenging consumer environment.
Looking ahead to fiscal 2025, we anticipate continued low-single digit volume growth as demonstrated in the second half and the same strong adjusted free cash flow we have consistently delivered. We are confident in the strength
and resilience of our portfolio, as reflected by the Board’s decision to raise our dividend by nearly 13% following last year’s 10% increase. As we move forward we intend to deliver enhanced value to our shareholders by continuing to
focus on three key objectives: accelerating organic growth, increasing margins from improved operations, and deleveraging.”
|
September Quarter
|
Reported
|
Fiscal Year
|
Reported
|
|||||||||||||||||||||
GAAP results
|
2024
|
2023
|
%
|
2024
|
2023
|
%
|
||||||||||||||||||
Net sales
|
$
|
3,168
|
$
|
3,087
|
3
|
%
|
$
|
12,258
|
$
|
12,664
|
(3
|
%)
|
||||||||||||
Operating income
|
269
|
301
|
(11
|
%)
|
937
|
1,079
|
(13
|
%)
|
||||||||||||||||
EPS (diluted)
|
1.26
|
1.55
|
(19
|
%)
|
4.38
|
4.95
|
(12
|
%)
|
September Quarter
|
Reported
|
Comparable
|
Fiscal Year
|
Reported
|
Comparable
|
||||||||||||||||||||||||
Adjusted non-GAAP results
|
2024
|
2023
|
%
|
%
|
2024
|
2023
|
%
|
%
|
|||||||||||||||||||||
Operating EBITDA
|
546
|
547
|
flat
|
(1
|
%)
|
2,045
|
2,053
|
flat
|
(1
|
%)
|
|||||||||||||||||||
Adjusted EPS (diluted)
|
2.27
|
2.28
|
flat
|
(1
|
%)
|
7.62
|
7.42
|
3
|
%
|
2
|
%
|
(1)
|
Adjusted non-GAAP results exclude items not considered to be ongoing operations. In addition, comparable change %
excludes the impacts of foreign currency, acquisitions, and recent divestitures. Further details related to non-GAAP measures and reconciliations can be found under our “Non-GAAP Financial Measures and Estimates” section and in
reconciliation tables in this release. In millions of USD, except per share data.
|
•
|
Adjusted earnings per share range of $6.10-$6.60 (Fiscal 2024 comparable ~$6.00)
|
•
|
Cash flow from operations of $1.125-$1.225 billion; free cash flow of $600-$700 million
|
•
|
Committed to further debt reduction along with return of capital to shareholders
|
Quarterly Period Ended
|
Fiscal Year Ended
|
|||||||||||||||
September 28, 2024
|
September 30, 2023
|
September 28, 2024
|
September 30, 2023
|
|||||||||||||
Net sales
|
$
|
3,168
|
$
|
3,087
|
$
|
12,258
|
$
|
12,664
|
||||||||
Costs and expenses:
|
||||||||||||||||
Cost of goods sold
|
2,557
|
2,481
|
10,005
|
10,354
|
||||||||||||
Selling, general and administrative
|
228
|
215
|
892
|
886
|
||||||||||||
Amortization of intangibles
|
57
|
62
|
234
|
243
|
||||||||||||
Business consolidation and other activities
|
52
|
28
|
190
|
102
|
||||||||||||
Operating income
|
269
|
301
|
937
|
1,079
|
||||||||||||
Other expense
|
7
|
18
|
15
|
31
|
||||||||||||
Interest expense, net
|
86
|
78
|
311
|
306
|
||||||||||||
Income before income taxes
|
176
|
205
|
611
|
742
|
||||||||||||
Income tax expense
|
28
|
19
|
95
|
133
|
||||||||||||
Net income
|
$
|
148
|
$
|
186
|
$
|
516
|
$
|
609
|
||||||||
Basic net income per share
|
$
|
1.29
|
$
|
1.59
|
$
|
4.48
|
$
|
5.07
|
||||||||
Diluted net income per share
|
1.26
|
1.55
|
4.38
|
4.95
|
||||||||||||
Outstanding weighted average shares (in millions)
|
||||||||||||||||
Basic
|
114.6
|
117.3
|
115.1
|
120.1
|
||||||||||||
Diluted
|
117.4
|
120.2
|
117.7
|
123.0
|
||||||||||||
(in millions of USD)
|
September 28, 2024
|
September 30, 2023
|
||||||
Cash and cash equivalents
|
$
|
1,095
|
$
|
1,203
|
||||
Accounts receivable
|
1,604
|
1,568
|
||||||
Inventories
|
1,624
|
1,557
|
||||||
Other current assets
|
244
|
205
|
||||||
Property, plant, and equipment
|
4,575
|
4,576
|
||||||
Goodwill, intangible assets, and other long-term assets
|
7,464
|
7,478
|
||||||
Total assets
|
$
|
16,606
|
$
|
16,587
|
||||
Current liabilities, excluding current debt
|
2,855
|
2,703
|
||||||
Current and long-term debt
|
8,315
|
8,980
|
||||||
Other long-term liabilities
|
1,828
|
1,688
|
||||||
Stockholders’ equity
|
3,608
|
3,216
|
||||||
Total liabilities and stockholders' equity
|
$
|
16,606
|
$
|
16,587
|
||||
Fiscal Year Ended
|
||||||||
(in millions of USD)
|
September 28, 2024
|
September 30, 2023
|
||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
516
|
$
|
609
|
||||
Depreciation
|
623
|
575
|
||||||
Amortization of intangibles
|
234
|
243
|
||||||
Non-cash interest, net
|
(79
|
)
|
(61
|
)
|
||||
Share-based compensation expense
|
46
|
42
|
||||||
Deferred income tax
|
(96
|
)
|
(117
|
)
|
||||
Loss on divestitures
|
57
|
-
|
||||||
Settlement of derivatives
|
26
|
36
|
||||||
Other non-cash operating activities, net
|
22
|
22
|
||||||
Changes in working capital
|
56
|
266
|
||||||
Net cash from operating activities
|
1,405
|
1,615
|
||||||
Cash flows from investing activities:
|
||||||||
Additions to property, plant, and equipment, net
|
(551
|
)
|
(689
|
)
|
||||
Acquisitions, divestitures, and other activities
|
(21
|
)
|
(87
|
)
|
||||
Net cash from investing activities
|
(572
|
)
|
(776
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Repayments on long-term borrowings
|
(3,884
|
)
|
(869
|
)
|
||||
Proceeds from long-term borrowings
|
3,150
|
496
|
||||||
Repurchase of common stock
|
(120
|
)
|
(601
|
)
|
||||
Proceeds from issuance of common stock
|
48
|
36
|
||||||
Dividends paid
|
(139
|
)
|
(127
|
)
|
||||
Other, net
|
(21
|
)
|
(6
|
)
|
||||
Net cash from financing activities
|
(965
|
)
|
(1,071
|
)
|
||||
Effect of currency translation on cash
|
25
|
25
|
||||||
Net change in cash and cash equivalents
|
(108
|
)
|
(207
|
)
|
||||
Cash and cash equivalents at beginning of period
|
1,203
|
1,410
|
||||||
Cash and cash equivalents at end of period
|
$
|
1,095
|
$
|
1,203
|
||||
Non-U.S. GAAP Free Cash Flow:
|
||||||||
Cash flow from operating activities
|
$
|
1,405
|
$
|
1,615
|
||||
Additions to property, plant, and equipment (net)
|
(551
|
)
|
(689
|
)
|
||||
Non-U.S. GAAP Free Cash Flow
|
$
|
854
|
$
|
926
|
Quarterly Period Ended September 28, 2024
|
||||||||||||||||||||
(in millions of USD)
|
Consumer Packaging - International
|
Consumer Packaging- North America
|
Health, Hygiene & Specialties
|
Flexibles
|
Total
|
|||||||||||||||
Net sales
|
$
|
999
|
$
|
840
|
$
|
642
|
$
|
687
|
$
|
3,168
|
||||||||||
Operating income
|
$
|
72
|
$
|
124
|
$
|
11
|
$
|
62
|
$
|
269
|
||||||||||
Depreciation and amortization
|
82
|
56
|
47
|
32
|
217
|
|||||||||||||||
Business consolidation and other activities
|
29
|
(11
|
)
|
20
|
14
|
52
|
||||||||||||||
Other non-cash charges
|
3
|
2
|
1
|
2
|
8
|
|||||||||||||||
Operating EBITDA
|
$
|
186
|
$
|
171
|
$
|
79
|
$
|
110
|
$
|
546
|
||||||||||
Quarterly Period Ended September 30, 2023
|
||||||||||||||||||||
Reported net sales
|
$
|
1,000
|
$
|
786
|
$
|
630
|
$
|
671
|
$
|
3,087
|
||||||||||
Foreign currency, acquisitions & divestitures
|
(25
|
)
|
14
|
(10
|
)
|
1
|
(20
|
)
|
||||||||||||
Comparable net sales (1)
|
$
|
975
|
$
|
800
|
$
|
620
|
$
|
672
|
$
|
3,067
|
||||||||||
Operating income
|
$
|
84
|
$
|
94
|
$
|
36
|
$
|
87
|
$
|
301
|
||||||||||
Depreciation and amortization
|
80
|
58
|
45
|
29
|
212
|
|||||||||||||||
Business consolidation and other activities
|
18
|
7
|
2
|
1
|
28
|
|||||||||||||||
Other non-cash charges
|
2
|
2
|
1
|
1
|
6
|
|||||||||||||||
Foreign currency, acquisitions & divestitures
|
(0
|
)
|
6
|
-
|
-
|
6
|
||||||||||||||
Comparable operating EBITDA (1)
|
$
|
184
|
$
|
167
|
$
|
84
|
$
|
118
|
$
|
553
|
||||||||||
Fiscal Year Ended September 28, 2024
|
||||||||||||||||||||
(in millions of USD)
|
Consumer Packaging - International
|
Consumer Packaging- North America
|
Health, Hygiene & Specialties
|
Flexibles
|
Total
|
|||||||||||||||
Net sales
|
$
|
3,843
|
$
|
3,121
|
$
|
2,538
|
$
|
2,756
|
$
|
12,258
|
||||||||||
Operating income
|
$
|
186
|
$
|
366
|
$
|
75
|
$
|
310
|
$
|
937
|
||||||||||
Depreciation and amortization
|
322
|
227
|
183
|
125
|
857
|
|||||||||||||||
Business consolidation and other activities
|
124
|
6
|
43
|
17
|
190
|
|||||||||||||||
Other non-cash charges
|
14
|
14
|
23
|
10
|
61
|
|||||||||||||||
Operating EBITDA
|
$
|
646
|
$
|
613
|
$
|
324
|
$
|
462
|
$
|
2,045
|
||||||||||
Fiscal Year Ended September 30, 2023
|
||||||||||||||||||||
Reported net sales
|
$
|
4,031
|
$
|
3,122
|
$
|
2,627
|
$
|
2,884
|
$
|
12,664
|
||||||||||
Foreign currency, acquisitions & divestitures
|
(16
|
)
|
42
|
9
|
12
|
47
|
||||||||||||||
Comparable net sales (1)
|
$
|
4,015
|
$
|
3,164
|
$
|
2,636
|
$
|
2,896
|
$
|
12,711
|
||||||||||
Operating income
|
$
|
273
|
$
|
346
|
$
|
127
|
$
|
333
|
$
|
1,079
|
||||||||||
Depreciation and amortization
|
310
|
217
|
177
|
114
|
818
|
|||||||||||||||
Business consolidation and other activities
|
50
|
23
|
22
|
7
|
102
|
|||||||||||||||
Other non-cash charges
|
25
|
12
|
8
|
9
|
54
|
|||||||||||||||
Foreign currency, acquisitions & divestitures
|
(2
|
)
|
18
|
5
|
1
|
22
|
||||||||||||||
Comparable operating EBITDA (1)
|
$
|
656
|
$
|
616
|
$
|
339
|
$
|
464
|
$
|
2,075
|
||||||||||
(1)
|
The prior year comparable basis change excludes the impacts of foreign currency, acquisitions, and divestitures. Further details
related to non-GAAP measures and reconciliations can be found under our “Non-GAAP Financial Measures and Estimates” section or in reconciliation tables in this release.
|
Quarterly Period Ended
|
Fiscal Year Ended
|
|||||||||||||||
September 28, 2024
|
September 30, 2023
|
September 28, 2024
|
September 30, 2023
|
|||||||||||||
Net income
|
$
|
148
|
$
|
186
|
$
|
516
|
$
|
609
|
||||||||
Add: other expense
|
7
|
18
|
15
|
31
|
||||||||||||
Add: interest expense
|
86
|
78
|
311
|
306
|
||||||||||||
Add: income tax expense
|
28
|
19
|
95
|
133
|
||||||||||||
Operating income
|
$
|
269
|
$
|
301
|
$
|
937
|
$
|
1,079
|
||||||||
Add: business consolidation and other activities
|
52
|
28
|
190
|
102
|
||||||||||||
Add: Impact of hyperinflation
|
—
|
—
|
15
|
—
|
||||||||||||
Add: other non-cash charges (1)
|
8
|
6
|
46
|
54
|
||||||||||||
Adjusted operating income (3)
|
$
|
329
|
$
|
335
|
$
|
1,188
|
$
|
1,235
|
||||||||
Add: depreciation
|
160
|
150
|
623
|
575
|
||||||||||||
Add: amortization of intangibles
|
57
|
62
|
234
|
243
|
||||||||||||
Operating EBITDA (3)
|
$
|
546
|
$
|
547
|
$
|
2,045
|
$
|
2,053
|
||||||||
Net income per diluted share
|
$
|
1.26
|
$
|
1.55
|
$
|
4.38
|
$
|
4.95
|
||||||||
Other expense, net
|
0.06
|
0.15
|
0.13
|
0.25
|
||||||||||||
Business consolidation and other activities
|
0.44
|
0.23
|
1.61
|
0.83
|
||||||||||||
Impact of hyperinflation
|
—
|
—
|
0.13
|
—
|
||||||||||||
Amortization of intangibles from acquisitions (2)
|
0.49
|
0.52
|
1.99
|
1.98
|
||||||||||||
Income tax impact on items above
|
0.02
|
(0.17
|
)
|
(0.62
|
)
|
(0.59
|
)
|
|||||||||
Foreign currency, acquisitions, and divestitures
|
0.01
|
0.05
|
||||||||||||||
Adjusted net income per diluted share (3)
|
$
|
2.27
|
$
|
2.29
|
$
|
7.62
|
$
|
7.47
|
||||||||
Estimated Fiscal 2025
|
||||
Cash flow from operating activities
|
$
|
1,125-$1,225
|
||
Net additions to property, plant, and equipment
|
(525
|
)
|
||
Free cash flow (3)
|
$
|
600-$700
|
(1)
|
Other non-cash charges are primarily stock compensation expense
|
(2)
|
Amortization of intangibles from acquisition are added back to better align our calculation of adjusted EPS with peers.
|
(3)
|
Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted
in the United States (“GAAP”). These non-GAAP financial measures should not be considered as alternatives to operating or net income or cash flows from operating activities, in each case determined in accordance with GAAP. Organic sales
growth and comparable basis measures exclude the impact of currency translation effects and acquisitions. These non-GAAP financial measures may be calculated differently by other companies, including other companies in our industry, limiting
their usefulness as comparative measures. Berry’s management believes that adjusted net income and other non-GAAP financial measures are useful to our investors because they allow for a better period-over-period comparison of operating
results by removing the impact of items that, in management’s view, do not reflect our core operating performance.
|